Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1989;74:624-636
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JELOVSEK, F. R.
Right arrow Articles by CHEN, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JELOVSEK, F. R.
Right arrow Articles by CHEN, J. J.

Prediction of Risk for Human Developmental Toxicity

How Important Are Animal Studies for Hazard Identification?

FREDERICK R. JELOVSEK, MD, FACOG, DONALD R. MATTISON, MD and JAMES J. CHEN, PhD

From the Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock; and the Division of Human Risk Assessment and the Biometry Staff, National Center for Toxicological Research, Jefferson, Arkansas.

To determine how developmental toxicity studies in animals can be used in human risk assessment, a data base was assembled from the literature. It included probable, suspected, unknown, and probably negative teratogenic or embryotoxic drugs and chemical compounds. For each of 175 substances, we recorded the results of any developmental toxicity testing in up to 14 animal species and any reports of mutagenicity or carcinogenicity. Logistic regression and discriminant analysis were used to predict a compound's effect in humans. A measure of the number of positive animal studies and bacterial mutagenicity were important predictors in both models, as were the specific results in hamsters and subhuman primates. The fact that a compound had been tested at all in subhuman primates was more important in predicting human risk than was the result itself. The methods used correctly classified the study compounds 63–91% of the time, depending upon how the suspicious and unknown compounds were treated. The models had a sensitivity of 62–75%, a positive predictive value of 75–100%, and a negative predictive value of 64–91%. These findings imply that studies in laboratory animals carry weight in predicting human developmental toxicity. The more animal species in which a compound is positive, the more likely it is to have a human effect, albeit not the same effect as in the animals. Clinicians should not ignore developmental toxicity tests in animals "because laboratory rats are not like humans."




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. NATHANSON, E. MOREAU, C. MERLET-BENICHOU, and T. GILBERT
In Utero and in Vitro Exposure to {beta}-Lactams Impair Kidney Development in the Rat
J. Am. Soc. Nephrol., May 1, 2000; 11(5): 874 - 884.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.